Authors: | Pereira, P. M. R.; Roberts, S.; Figueira, F.; Tomé, J. P. C.; Reiner, T.; Lewis, J. S. |
Article Title: | PET/CT imaging with an (18)F-labeled galactodendritic unit in a Galectin-1–overexpressing orthotopic bladder cancer model |
Abstract: | Galectins are carbohydrate-binding proteins overexpressed in bladder cancer (BCa) cells. Dendritic galactose moieties have a high affinity for galectin-expressing tumor cells. We radiolabeled a dendritic galactose carbohydrate with 18F (18F-labeled galactodendritic unit 4) and examined its potential in imaging urothelial malignancies. Methods: The 18F-labeled first-generation galactodendritic unit 4 was obtained from its tosylate precursor. We conducted in vivo studies in a galectin-expressing UMUC3 orthotopic BCa model to determine the ability of 18F-labeled galactodendritic unit 4 to image BCa. Results: Intravesical administration of 18F-labeled galactodendritic unit 4 allowed specific accumulation of the carbohydrate radiotracer in galectin-1–overexpressing UMUC3 orthotopic tumors when imaged with PET. The 18F-labeled galactodendritic unit 4 was not found to accumulate in nontumor murine bladders. Conclusion: The 18F-labeled galactodendritic unit 4 and similar analogs may be clinically relevant and exploitable for PET imaging of galectin-1–overexpressing bladder tumors. © 2020 by the Society of Nuclear Medicine and Molecular Imaging |
Keywords: | bladder cancer; pet/ct imaging; galectins; 18f-radiochemistry; dendritic carbohydrate |
Journal Title: | Journal of Nuclear Medicine |
Volume: | 61 |
Issue: | 9 |
ISSN: | 0161-5505 |
Publisher: | Society of Nuclear Medicine |
Date Published: | 2020-09-01 |
Start Page: | 1369 |
End Page: | 1375 |
Language: | English |
DOI: | 10.2967/jnumed.119.236430 |
PUBMED: | 32005776 |
PROVIDER: | scopus |
PMCID: | PMC7456169 |
DOI/URL: | |
Notes: | Article -- Source: Scopus |